Hsa-mir-182 downregulates RASA1 and suppresses lung squamous cell carcinoma cell proliferation

Clin Lab. 2014;60(1):155-9. doi: 10.7754/clin.lab.2013.121131.

Abstract

Background: This work was undertaken to identify the differences in expression of miRNAs, which would predict early-stage non-small cell lung cancer prognosis and recurrence. The results may be helpful to demonstrate one mechanism of lung squamous cancer proliferation.

Methods: Lung squamous cell carcinoma specimens were collected at the time of surgery. Microarray of expression of specific miRNAs in lung squamous cell cancer tissue, were assessed by qRT-PCR.

Results: We found that the hsa-mir-182 family are highly expressed in lung squamous cell carcinoma. Paradoxically, our study reveals mir-182 suppresses cell proliferation in vivo. RASA1 is related to cell apoptosis. We further show that mir-182 downregulates RASA1.

Conclusions: We provide first time evidence through tissue microarray and quantitative PCR validation of mir-182 in the expression of lung squamous cell carcinoma. Our data provide a possible mechanism for lung cancer cell proliferation in lung squamous cell cancer and may be helpful in discovering a new strategy to reveal lung squamous cell carcinoma progress.

MeSH terms

  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / pathology
  • Cell Proliferation*
  • Down-Regulation*
  • Humans
  • Lung Neoplasms / metabolism*
  • Lung Neoplasms / pathology
  • MicroRNAs / genetics*
  • Serum Albumin / metabolism*
  • p120 GTPase Activating Protein / metabolism*

Substances

  • MicroRNAs
  • RASA1 protein, human
  • Serum Albumin
  • p120 GTPase Activating Protein